Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medical Groups Call For More Flexibility, Time In EHR Stage 2 Meaningful Use

Executive Summary

A group of 35 medical organizations, including the American Medical Association, are calling for more flexibility and time in meeting criteria for meaningful use of electronic health records as the HHS Office of the National Coordinator for Health Information Technology continues to develop stage 2 criteria.

You may also be interested in...

IOM Calls For More Government Oversight Of Health IT

The Institute of Medicine offers a series of recommendations to HHS to enhance the agency’s oversight of health IT, and calls on the private sector to be more engaged in sharing safety data with both the public and private sectors.

IOM Wants More Government Oversight For Health Information Technology

CMS Reveals Early Registration Numbers For Electronic Health Record Incentives

Agency calls interest "strong" while National Coordinator for Health Information Technology Blumenthal calls 2011 "the age of meaningful use of health information."

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts